Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Interactive Tools
Sponsored
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Nathan H. Fowler, MD, MD Anderson Cancer Center
home
Articles
ASH 2020 Updates in Relapsed/Refractory B-Cell Lymphomas
January 22nd 2021
ASH 2020 Updates in Non-CLL B-Cell Lymphomas
January 22nd 2021
ASH 2020 Updates in CLL
January 22nd 2021
Treatment of R/R DLBCL: Beyond CAR T Therapy
September 22nd 2020
Phase 2B SADAL Trial in R/R DLBCL
September 22nd 2020
RE-MIND Study in R/R DLBCL
September 22nd 2020
L-MIND Study in R/R DLBCL
September 22nd 2020
CAR T in Transplant-Eligible and Transplant-Ineligible DLBCL
September 22nd 2020
Standard of Care for Relapsed/Refractory DLBCL
September 22nd 2020
Closing Thoughts on Treatment of R/R DLBCL
July 15th 2020
Improving Outcomes in Patients With R/R DLBCL
July 15th 2020
Emerging Therapies for R/R DLBCL
July 15th 2020
Safety and Efficacy of Oral Agents in R/R DLBCL
July 15th 2020
Treatment of R/R DLBCL: CD19-Directed Therapy vs CAR T
July 15th 2020
CD19-Directed Therapies for Treatment of R/R DLBCL
July 15th 2020
CAR T in R/R DLBCL: Safety and Patient Selection
July 15th 2020
ASCO 2020 Data: CAR T in R/R DLBCL
July 15th 2020
Role of CAR T-cell Therapy in R/R DLBCL
July 15th 2020
Treatment in Transplant-ineligible R/R DLBCL
July 15th 2020
Prognosis of R/R DLBCL
July 15th 2020
NEXT PAGE
<
1
2
>
PREVIOUS PAGE